NO20005400D0 - Kinoloner anvendt som MRS-inhibitorer og baktericider - Google Patents
Kinoloner anvendt som MRS-inhibitorer og baktericiderInfo
- Publication number
- NO20005400D0 NO20005400D0 NO20005400A NO20005400A NO20005400D0 NO 20005400 D0 NO20005400 D0 NO 20005400D0 NO 20005400 A NO20005400 A NO 20005400A NO 20005400 A NO20005400 A NO 20005400A NO 20005400 D0 NO20005400 D0 NO 20005400D0
- Authority
- NO
- Norway
- Prior art keywords
- bactericides
- mrs
- inhibitors
- quinolones
- quinolones used
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809050.9A GB9809050D0 (en) | 1998-04-29 | 1998-04-29 | Novel compounds |
| GBGB9824571.5A GB9824571D0 (en) | 1998-11-09 | 1998-11-09 | Novel compounds |
| PCT/EP1999/002648 WO1999055677A1 (en) | 1998-04-29 | 1999-04-15 | Quinolones used as mrs inhibitors and bactericides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005400D0 true NO20005400D0 (no) | 2000-10-26 |
| NO20005400L NO20005400L (no) | 2000-10-26 |
Family
ID=26313554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005400A NO20005400L (no) | 1998-04-29 | 2000-10-26 | Kinoloner anvendt som MRS-inhibitorer og baktericider |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6320051B1 (no) |
| EP (1) | EP1084110A1 (no) |
| JP (1) | JP2002513005A (no) |
| KR (1) | KR20010043131A (no) |
| CN (1) | CN1307565A (no) |
| AR (1) | AR018199A1 (no) |
| AU (1) | AU3523599A (no) |
| BR (1) | BR9909994A (no) |
| CA (1) | CA2330564A1 (no) |
| CO (1) | CO5080763A1 (no) |
| HU (1) | HUP0103093A3 (no) |
| IL (1) | IL138906A0 (no) |
| NO (1) | NO20005400L (no) |
| PL (1) | PL343680A1 (no) |
| TR (1) | TR200003170T2 (no) |
| WO (1) | WO1999055677A1 (no) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040014121A1 (en) * | 1996-04-18 | 2004-01-22 | Smithkline Beecham Corporation | Novel compounds |
| GB9822241D0 (en) * | 1998-10-12 | 1998-12-09 | Smithkline Beecham Plc | Novel compounds |
| GB9827467D0 (en) * | 1998-12-15 | 1999-02-10 | Zeneca Ltd | Chemical compounds |
| EP1466603A3 (en) * | 1999-05-05 | 2004-10-20 | Merck & Co., Inc. | Novel catechols as antimicrobial agents |
| CA2372079A1 (en) * | 1999-05-05 | 2000-11-09 | Aaron H. Leeman | Novel catechols as antimicrobial agents |
| GB9911594D0 (en) * | 1999-05-19 | 1999-07-21 | Smithkline Beecham Plc | Novel compounds |
| JP2003500397A (ja) * | 1999-05-19 | 2003-01-07 | スミスクライン ビーチャム パブリック リミテッド カンパニー | Ｍｒｓ阻害剤としての２−ｎｈ−ピリドンおよびピリミドン |
| US20040039017A1 (en) * | 2000-12-11 | 2004-02-26 | Dashyant Dhanak | Urotensin-II receptor antagonists |
| AU2002239506A1 (en) * | 2000-12-11 | 2002-06-24 | Smith Kline Beecham Corporation | Urotensin-ii receptor antagonists |
| EP1359915A4 (en) * | 2001-01-26 | 2004-07-21 | Smithkline Beecham | UROTENSIN-II RECEPTOR ANTAGONISTS |
| SE0202134D0 (sv) * | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
| KR100897642B1 (ko) | 2002-12-20 | 2009-05-14 | 글락소 그룹 리미티드 | 신경 장애 치료용 벤즈아제핀 유도체 |
| WO2004078119A2 (en) | 2003-03-03 | 2004-09-16 | Replidyne Inc. | Substituted thiophenes with antibacterial activity |
| GB0304809D0 (en) * | 2003-03-03 | 2003-04-09 | Glaxo Group Ltd | Novel compounds |
| US20040224981A1 (en) * | 2003-05-01 | 2004-11-11 | Nebojsa Janjic | Antibacterial methods and compositions |
| EP1706384A1 (en) * | 2004-01-07 | 2006-10-04 | AstraZeneca AB | Therapeutic agents i |
| JO3077B1 (ar) * | 2005-07-28 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينولين مضادة للبكتيريا |
| FR2902100A1 (fr) * | 2006-06-13 | 2007-12-14 | Sanofi Aventis Sa | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique |
| US8697720B2 (en) | 2006-09-26 | 2014-04-15 | Crestone, Inc. | Substituted phenylether-thienopyridone compounds with antibacterial activity |
| WO2008039642A2 (en) | 2006-09-26 | 2008-04-03 | Replidyne, Inc. | Methods and compounds for treatment of clostridium based infection |
| WO2008039639A2 (en) * | 2006-09-26 | 2008-04-03 | Crestone, Inc. | Substituted thienopyridone compounds with antibacterial activity |
| US7994192B2 (en) | 2006-09-26 | 2011-08-09 | Crestone, Inc. | Substituted thienopyridone compounds with antibacterial activity |
| US7973050B2 (en) | 2006-09-26 | 2011-07-05 | Crestone, Inc. | Enantiomeric compounds with antibacterial activity |
| EP2091536B1 (en) * | 2006-09-26 | 2013-07-31 | Crestone, Inc. | Enantiomeric compounds with antibacterial activity |
| CN104546857B (zh) * | 2013-10-18 | 2017-01-04 | 北京北科德源生物医药科技有限公司 | 化合物naphthoylenequinazolone的抗菌用途 |
| CN110475777B (zh) * | 2017-03-30 | 2022-04-15 | 豪夫迈·罗氏有限公司 | 用于治疗和预防细菌感染的新吡啶并[2,3-b]吲哚化合物 |
| CN112939860B (zh) * | 2019-11-11 | 2022-11-11 | 山东畜牧兽医职业学院 | 一种治疗耐药性革兰阴阳性菌的化合物及其制备方法 |
| JP7747664B2 (ja) | 2020-05-20 | 2025-10-01 | エフ． ホフマン－ラ ロシュ アーゲー | 質量分析のためのベンジルピリジニウム試薬 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4005205A (en) * | 1974-04-24 | 1977-01-25 | Smith Kline & French Laboratories Limited | Compositions and methods for inhibiting H2 histamine receptors |
| GB8332091D0 (en) | 1983-12-01 | 1984-01-11 | Smith Kline French Lab | Chemical compounds |
| KR950005301B1 (ko) * | 1990-09-04 | 1995-05-23 | 주식회사대웅제약 | 신규한 퀴놀론 카르복실산 유도체 |
| KR960007566A (ko) * | 1994-08-19 | 1996-03-22 | 김정규 | 신규한 퀴놀릴아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도 |
-
1999
- 1999-04-15 CA CA002330564A patent/CA2330564A1/en not_active Abandoned
- 1999-04-15 KR KR1020007012024A patent/KR20010043131A/ko not_active Withdrawn
- 1999-04-15 CN CN99807809A patent/CN1307565A/zh active Pending
- 1999-04-15 EP EP99916927A patent/EP1084110A1/en not_active Withdrawn
- 1999-04-15 JP JP2000545837A patent/JP2002513005A/ja active Pending
- 1999-04-15 BR BR9909994-2A patent/BR9909994A/pt not_active Application Discontinuation
- 1999-04-15 HU HU0103093A patent/HUP0103093A3/hu unknown
- 1999-04-15 IL IL13890699A patent/IL138906A0/xx unknown
- 1999-04-15 AU AU35235/99A patent/AU3523599A/en not_active Abandoned
- 1999-04-15 PL PL99343680A patent/PL343680A1/xx unknown
- 1999-04-15 US US09/674,102 patent/US6320051B1/en not_active Expired - Fee Related
- 1999-04-15 WO PCT/EP1999/002648 patent/WO1999055677A1/en not_active Ceased
- 1999-04-15 TR TR2000/03170T patent/TR200003170T2/xx unknown
- 1999-04-27 AR ARP990101937A patent/AR018199A1/es unknown
- 1999-04-29 CO CO99025654A patent/CO5080763A1/es unknown
-
2000
- 2000-10-26 NO NO20005400A patent/NO20005400L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0103093A2 (hu) | 2002-02-28 |
| AR018199A1 (es) | 2001-10-31 |
| BR9909994A (pt) | 2000-12-26 |
| CO5080763A1 (es) | 2001-09-25 |
| US6320051B1 (en) | 2001-11-20 |
| IL138906A0 (en) | 2001-11-25 |
| AU3523599A (en) | 1999-11-16 |
| CA2330564A1 (en) | 1999-11-04 |
| PL343680A1 (en) | 2001-08-27 |
| TR200003170T2 (tr) | 2001-01-22 |
| HUP0103093A3 (en) | 2002-03-28 |
| JP2002513005A (ja) | 2002-05-08 |
| EP1084110A1 (en) | 2001-03-21 |
| WO1999055677A1 (en) | 1999-11-04 |
| CN1307565A (zh) | 2001-08-08 |
| KR20010043131A (ko) | 2001-05-25 |
| NO20005400L (no) | 2000-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005400D0 (no) | Kinoloner anvendt som MRS-inhibitorer og baktericider | |
| NO20012688D0 (no) | Benzamidderivater og anvendelse derav som APOB-100 sekresjonsinhibitorer | |
| DK1133477T3 (da) | Substituerede benzimidazoler og deres anvendelse som parpinhibitorer | |
| NO991922L (no) | Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer | |
| NO20032668L (no) | Gyraseinhibitorer og anvendelser derav | |
| DK1251848T3 (da) | Gyraseinhibitorer og anvendelse deraf | |
| IS2529B (is) | Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar | |
| NO20011950L (no) | Farmasöytiske blandinger som inneholder poly(ADP-ribose) glukohydrolaseinhibitorer og fremgangsmåter for anvendelse avsamme | |
| DK0934301T3 (da) | Aminothiophencarboxylsyreamider og anvendelse deraf som phosphodiesteraseinhibitorer | |
| ID18142A (id) | Inhibitor metaloprotease 1,4-heterosiklik | |
| IS6385A (is) | Ný notkun og nýjar N-asabísýkló-amíð afleiður | |
| NO20014823D0 (no) | Heterocyklus-holdige bifenyl-aP2-inhibitorer og metode | |
| ID18141A (id) | Inhibitor metaloprotease 1,3-diheterosiklik | |
| ID27574A (id) | Inhibitor enzim | |
| DE69942123D1 (de) | FACTOR VIIa INHIBITORE | |
| NO992492D0 (no) | Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer | |
| DK0944590T3 (da) | Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer | |
| IS5827A (is) | Múskarín gerandefni og mótlyf | |
| NO995513D0 (no) | N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-A agonister | |
| DE59806475D1 (de) | Urokinase-inhibitoren | |
| NO20003814D0 (no) | Trombininhibitorer | |
| ATE252547T1 (de) | Matrixmetalloproteinaseinhibitoren | |
| DK1214302T3 (da) | Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere | |
| PT1339695E (pt) | Inibidores da farnesiltransferase | |
| NO20003142L (no) | Substituerte isokinolin-derivater og anvendelse derav som antikrampemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |